Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Cody Foster

Pain Medicine Coon Rapids, MN Medical Doctor

NPI 1760914725 CMS profile 11392271

2104 Northdale Blvd Nw Ste 220, Ste 102, Coon Rapids, MN 55433

Open in the dashboard

General payments

$36,412

241 records reported · program years 2022–2025

Research payments

$205

Paid to them · 1 record reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Cody Foster of Coon Rapids, MN is reported in the CMS Open Payments database as having received $36,412 across 241 general payments and $205 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $11,776 58
2024 General $16,487 75
2024 Research $205 1
2023 General $6,596 86
2022 General $1,552 22

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Cody Foster
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Cody Foster were reported at $11,776. Among 2,779 Pain Medicine profiles paid that year, the median was $458 and the middle half received between $124 and $1,401.

Show as a table
Year Cody Foster Pain Medicine median Middle half National median
2019 $0 $498 $126–$1,682 $163
2020 $0 $284 $80–$910 $114
2021 $0 $399 $112–$1,219 $132
2022 $1,552 $455 $137–$1,484 $149
2023 $6,596 $484 $128–$1,495 $160
2024 $16,487 $498 $131–$1,540 $164
2025 $11,776 $458 $124–$1,401 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Medtronic, Inc. $25,042 149 payments
  2. Abbott Laboratories $6,190 49 payments
  3. Spinal Simplicity, LLC $2,219 13 payments
  4. Relievant Medsystems, Inc. $1,646 9 payments
  5. Merit Medical Systems Inc $700 2 payments
  6. Boston Scientific Corporation $167 2 payments
  7. Nevro Corp. $139 2 payments
  8. Saluda Medical Americas, Inc. $87 3 payments
  9. Curonix LLC $71 4 payments
  10. BIOTRONIK NRO, Inc. $52 2 payments
  11. Other $100 6 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $18,738 7 payments
  2. Travel and Lodging $9,424 49 payments
  3. Food and Beverage $7,551 183 payments
  4. Consulting Fee $700 2 payments
Products named General payments · program years 2022–2025
  1. INTELLIS ADAPTIVESTIM $21,097 77 payments
  2. PROCLAIM $4,868 34 payments
  3. SYNCHROMEDII $2,445 49 payments
  4. HA MINUTEMAN G3-R $1,706 12 payments
  5. Intracept Pain $1,646 9 payments
  6. Intracept Pain $1,646 9 payments
  7. Intracept Pain $1,646 9 payments
  8. Intracept Pain $1,646 9 payments
  9. OSTEOCOOL RF ABLATION SYSTEM $1,232 13 payments
  10. LIBERTY SI $513 1 payment
  11. Other $2,672 54 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2022–2025
  1. Medtronic, Inc. $205 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

745

Median for Interventional Pain Management: 1,220

Drug cost

$6,560

Median for Interventional Pain Management: $39,344

Branded share of claims

22.4%

Median for Interventional Pain Management: 34.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Cephalexin Generic 185 $1,724
Mupirocin Generic 172 $1,289
Naloxone Hcl Generic 13 $937
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 130 $891
Clindamycin Hcl Generic 81 $767
Oxycodone Hcl Generic 108 $667
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 37 $238
Tramadol Hcl Generic 19 $47

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,476 Part D prescribers listed as Interventional Pain Management; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 78 billing codes

Paid by Medicare

$233,580

Medicare's payments for the services billed

Medicare patients

591

Average age 67

Services billed

1,828

390 women, 201 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 70%
Depression 54%
Chronic kidney disease 30%
Diabetes 29%
Ischemic heart disease 24%
COPD 21%
Heart failure 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

242 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Minnesota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record